BLOOMBERG Countdown January 28, 2015
Hello, welcome to countdown. We have earnings from roche. Sales come in at 47 point 5 billion swiss francs. But is pretty much in line. The estimate was for 47. 1. Fast that is pretty much in line. They raised the dividend. They see the full year guidance being low to mid singledigit sales at a constant level. Oncology and pharmaceuticals are the two key areas. It is up 4 for the air for the year. These are the numbers i am getting. The core operating profit comes in at 17. 6. Rossi is further d...
Source: archive.org